OTC Pharmaceuticals in Mexico
| Publication Date | January 2008 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 32 |
| ISBN Number | not applicable |
| Product Code | DAT02657 |
Summary
Datamonitor's OTC Pharmaceuticals in Mexico industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of the industry's recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of the industry
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by both value and volume
- Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
- Market shares are covered by manufacturer and/or brand
- Also features market breakdown by distribution channel
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange v the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.
Content
- Executive Summary
- Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
- Chapter 2 Market Value
- Chapter 3 Market Segmentation I
- Chapter 4 Market Segmentation Ii
- Chapter 5 Market Share
- Chapter 6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
- Chapter 7 Leading Companies
- 7.1 Dsm Group
- 7.2 Bayer Ag
- 7.3 Boehringer Ingelheim Gmbh
- Chapter 8 Distribution
- Chapter 9 Market Forecasts
- 9.1 Market Value Forecast
- Chapter 10 Macroeconomic Indicators
- Chapter 11 Appendix
- 11.1 Methodology
- 11.2 Industry Associations
- 11.3 Related Datamonitor Research
- List Of Tables
- Table 1: Mexico Otc Pharmaceuticals Market Value: $ Billion, 2003-2007
- Table 2: Mexico Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
- Table 3: Mexico Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
- Table 4: Mexico Otc Pharmaceuticals Market Share: % Share, By Value, 2007
- Table 5: Key Facts: Dsm Group
- Table 6: Key Facts: Bayer Ag
- Table 7: Key Financials: Bayer Ag
- Table 8: Key Facts: Boehringer Ingelheim Gmbh
- Table 9: Key Financials: Boehringer Ingelheim Gmbh
- Table 10: Mexico Otc Pharmaceuticals Distribution: % Share, By Value, 2007
- Table 11: Mexico Otc Pharmaceuticals Market Value Forecast: $ Billion, 2007-2012
- Table 12: Mexico Size Of Population (Million) , 2003-2007
- Table 13: Mexico Gdp (Constant 2000 Prices, $ Billion), 2003-2007
- Table 14: Mexico Inflation, 2003-2007
- Table 15: Mexico Exchange Rate, 2003
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
Recently Viewed Products
- India: Booming Economy sees the Pharmaceutical Market Expand >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Battle for HIV drug market share getting fiercer - maybe too fierce for some >>
- Will Government Support see India’s Tourism Industry Reach $26 billion by 2010? >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















